ReNeuron, the Aim-quoted life sciences outfit that tests its products at hospitals in Dundee and Glasgow, was yesterday awarded "orphan drug" status for its experimental stem cell treatment for eye diseases.
http://www.scotsman.com/business/media-tech-leisure/reneuron-gets-orphan-drug-status-1-3065571
http://www.scotsman.com/business/media-tech-leisure/reneuron-gets-orphan-drug-status-1-3065571
No comments:
Post a Comment